BioSpace News Archive

Supernus Pharmaceutical, headquartered in Rockville, Maryland, is acquiring Biscayne Neurotherapeutics, located in Miami, Florida.

Atlantic Healthcare plc has secured acceptance of Camligo™ as the name for the Company’s first candidate product.

Rostec and the administration of the Primorsky Krai, a federal subject in the Russian Far East, have signed an agreement to establish an oncology center of proton therapy in the Primorsky region. The health clinic shall admit its first patients in 2022, its annual capacity shall be over 1000 patients.

On Tuesday, September 25th, Marc Sweeney, PharmD, M.Div., and ARMSRx Pharmacy Benefit Consultants, SVP of Clinical Consulting will present on the topic of “Taking 360-Degree View of Specialty Drug Issues and Trends Affecting Self-Insured Plans” at SIIA’s National Conference in Austin, Texas.

AstraZeneca joins Horizon’s Genomics Discovery Initiative

Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone

Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Australis Capital Inc. (“Australis”) today announced the common shares and warrants (together the “Units”) of Australis are expected to commence trading on the Canadian Securities Exchange

KVD900 Phase 2 On Track to Begin in 2018 for Potential On-Demand Treatment of Acute Attacks in Patients with Hereditary Angioedema

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it has closed on a private placement offering with institutional and private investors for the sale of shares of the Company’s common stock and shares of the Company’s newly designated Series D convertible preferred stock.

Optimum Nutrition (“ON”), the global leader in performance nutrition, today announced the arrival of an innovative twist on its ESSENTIAL AMIN.O. ENERGY™ product